Prerna Mewawalla/LinkedIn
Jun 25, 2025, 09:58
Prerna Mewawalla: Excited to Share our Multicenter Study on Real-world Outcomes of Sequential BCMA Therapies in RRMM After Belantamab
Prerna Mewawalla, Myeloma and Transplant Physician, Associate Professor at Drexel University, shared a post on X:
“Excited to share our multicenter study just published in Clinical Lymphoma, Myeloma and Leukemia:
Title: Real-World Outcomes of Sequential BCMA-directed therapies inRelapsed Refractory Multiple Myeloma After Belantamab Exposure
Authors: Prerna Mewawalla, Rachel Dileo, Yue Yin, Christopher Strouse, Hira Shaikh, James A Davis, Omar Alkharabsheh, Aliya Rashid, Nausheen Ahmed, Al-Ola Abdallah, Hamza Hashmi
You can read the Full Article on Clinical Lymphoma, Myeloma and Leukemia
Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared this post, adding:
“Congrats Prerna Mewawalla and all group on current publication ‘Real-world outcomes of sequential BCMA therapies in RRMM after belantamab”
More posts featuring Prerna Mewawalla
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 17, 2025, 06:42
Jul 17, 2025, 06:21
Jul 17, 2025, 01:09
Jul 16, 2025, 20:36
Jul 16, 2025, 20:13